急性缺血性卒中合并颅内未破裂动脉瘤机制及治疗进展  

Mechanism and treatment progress of acute ischaemic stroke with intracranial unruptured aneurysm

作　　者：王怡 陆登峰 王世鑫 刘广杰 孙晓欧[1] WANG Yi;LU Dengfeng;WANG Shixin;LIU Guangjie;SUN Xiaoou(Department of Neurosurgery,The First Affiliated Hospital of Soochow University,Suzhou 215006,China)

机构地区：[1]苏州大学附属第一医院神经外科,苏州215006

出　　处：《临床神经外科杂志》2024年第5期572-576,共5页Journal of Clinical Neurosurgery

基　　金：国家自然科学基金面上项目(81971171)。

摘　　要：颅内未破裂动脉瘤(IUA)的检出率在急性缺血性卒中(AIS)患者中远高于健康正常人群,当二者合并出现时优先治疗何种疾病是治疗的要点与难点所在。本文对缺血性卒中患者易于合并颅内动脉瘤的可能机制及危险因素做一综述,同时对AIS合并IUA患者的治疗措施进行回顾整理,以期为后续临床工作中该类患者的诊治提供参考,使其从后续可能的治疗措施中获益。The prevalence of intracranial unruptured aneurysms(IUA)in patients with acute ischemic stroke(AIS)is much higher than that in the healthy people.The key and difficult point of treatment is to prioritize which disease to treat first when the two merge.This article reviews the possible mechanisms and risk factors of patients with ischemic stroke combined with intracranial aneurysm,and reviews the treatment method of patients with AIS and IUA,in order to provide reference for the diagnosis and treatment of such patients in subsequent clinical work,so that they can benefit from possible subsequent treatment measures.

关 键 词：缺血性卒中 颅内未破裂动脉瘤 危险因素 破裂风险 治疗 

分 类 号：R651[医药卫生—外科学] R743[医药卫生—临床医学]